New combo therapy aims to shield Kids' hearts from kawasaki damage
NCT ID NCT04747847
First seen Feb 27, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This small pilot study tested two drugs—atorvastatin and anakinra—in 5 children with Kawasaki disease who had coronary artery abnormalities. The goal was to see if the combination is safe and can reduce artery inflammation to prevent future heart problems. The study focused on safety and early signs of benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAWASAKI DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Diego
San Diego, California, 92093, United States
Conditions
Explore the condition pages connected to this study.